PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,737,000 | +1.3% | 10,876,000 | 0.0% | 0.17% | +21.9% |
| Q4 2016 | $10,604,000 | +34.2% | 10,876,000 | +33.7% | 0.14% | +16.1% |
| Q3 2016 | $7,899,000 | +2.2% | 8,133,000 | 0.0% | 0.12% | +0.9% |
| Q2 2016 | $7,727,000 | +5.4% | 8,133,000 | 0.0% | 0.12% | -43.8% |
| Q1 2016 | $7,334,000 | +20.2% | 8,133,000 | +5.9% | 0.21% | +58.8% |
| Q4 2015 | $6,104,000 | -77.1% | 7,679,000 | -74.9% | 0.13% | -79.2% |
| Q3 2015 | $26,655,000 | +30.4% | 30,546,000 | +41.3% | 0.63% | +35.6% |
| Q2 2015 | $20,440,000 | +76.9% | 21,623,000 | +79.9% | 0.46% | +101.7% |
| Q1 2015 | $11,554,000 | -0.2% | 12,019,000 | +0.7% | 0.23% | +2.2% |
| Q4 2014 | $11,574,000 | -1.8% | 11,936,000 | -1.0% | 0.22% | -8.5% |
| Q3 2014 | $11,783,000 | -13.9% | 12,057,000 | +0.3% | 0.25% | -18.0% |
| Q2 2014 | $13,686,000 | -27.8% | 12,018,000 | -32.5% | 0.30% | -26.1% |
| Q1 2014 | $18,956,000 | – | 17,800,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|